Ramsay Health Care profit surges as Australian hospitals drive FY26 turnaround

Ramsay Health Care reports a sharp FY26 profit increase, with stronger Australian hospital activity, improved margins…

Pro Medicus signs $25M contract with US-based Valley Health

Pro Medicus' US subsidiary Visage Imaging has signed a seven-year, $25 million contract with Valley Health…

Pro Medicus posts 130% profit surge as forward contract book hits $1.34b

Pro Medicus posts a 130.3% rise in FY26 NPAT to $265.3m as revenue reaches $261.7m and…
Mesoblast research conept

Mesoblast completes Phase 3 low back pain trial treatment as pivotal readout approaches

Mesoblast has completed treatment of 350 patients in its pivotal Phase 3 trial for chronic low…

AVITA Medical raises 2026 outlook after record second quarter

AVITA Medical has raised its 2026 revenue guidance after delivering record quarterly revenue, while forecasting cash…

Resmed turns in record fourth quarter revenue of US$1.5B

AI-powered digital health solutions specialist Resmed Inc. has unveiled impressive results for its quarter ended June…

Control Bionics obtains FDA registration and device listing for NeuroStrip

Control Bionics' NeuroStrip platform has been registered and listed with the US Food and Drug Administration…
Aussie cash

Struggling long-term Lumos holders see hope as biotech stock inks A$1.1M order

The thing about biotech is that when a stock gets key approvals and smashes its third-phase-trial goals, it can tend to make overnight

Noxopharm adds to cancer treatment pipeline with positive new study results

Noxopharm’s new preclinical data has demonstrated the potential of its cancer-fighting technology and immune-amplifying oligonucleotides.

Wide Open Agriculture confirms multi-billion dollar skin care potential of lupin oil product

Wide Open Agriculture’s lupin oil product has been confirmed for both safety and its skin hydration…